Product Information

CAPTOPRIL 25 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.1743 per EA under NDC 00904710661. Its NADAC has been published 262 times since Aug 18, 2021.

FDA first approved this application on Dec 13, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the Captopril market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for CAPTOPRIL 25 MG TABLET has been published 262 times since Aug 18, 2021, and over the history we have for it it has declined 66.2%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.